Batabulin
CAS No. 195533-53-0
Batabulin ( T138067 )
产品货号. M23886 CAS No. 195533-53-0
Batabulin 是一种抗肿瘤化合物,它与 β-微管蛋白同种型的子集共价且选择性结合,从而破坏微管聚合。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1169 | 有现货 |
|
| 10MG | ¥1739 | 有现货 |
|
| 25MG | ¥2939 | 有现货 |
|
| 50MG | ¥4334 | 有现货 |
|
| 100MG | ¥5841 | 有现货 |
|
| 500MG | ¥11520 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥941 | 有现货 |
|
生物学信息
-
产品名称Batabulin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Batabulin 是一种抗肿瘤化合物,它与 β-微管蛋白同种型的子集共价且选择性结合,从而破坏微管聚合。
-
产品描述Batabulin is an antitumor compound, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin affects cell morphology and leads to cell-cycle arrest ultimately induce apoptotic cell death.
-
体外实验Cell Cycle Analysis Cell Line:MCF7 cells Concentration:30 nM, 100 nM and 300 nM Incubation Time:24 hours Result:Showed an arrest at the G2/M cell-cycle boundary.Apoptosis Analysis Cell Line:MCF7 cells Concentration:30 nM, 100 nM and 300 nM Incubation Time:24 hours or 48 hours Result:25-30% of cells showed the reduced DNA content characteristic of apoptotic cells.
-
体内实验Animal Model:Male athymic nude mice (nu/nu) (6-8 week-old, 20-25 g) injected with CCRF-CEM cells Dosage:40 mg/kg Administration:Intraperitoneal injection; once per week; on days 5, 12, and 19 Result:Impaired the growth of the drug-sensitive CCRF-CEM tumors.
-
同义词T138067
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis|Tubulin β
-
研究领域——
-
适应症——
化学信息
-
CAS Number195533-53-0
-
分子量371.26
-
分子式C13H7F6NO3S
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (269.35 mM; Need ultrasonic)
-
SMILESO=S(C1=C(F)C(F)=C(F)C(F)=C1F)(NC2=CC=C(OC)C(F)=C2)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shan B, et al. Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5686-91.
产品手册
关联产品
-
Tetrac
Tetrac (Tetraiodothyroacetic acid),L-甲状腺素 (T4) 的天然衍生物,是甲状腺素整合素受体拮抗剂。Tetrac 阻断 T4 和 3,5,3'-triiodo-L-thyronine (T3) 在整联蛋白 αvβ3 上甲状腺激素的细胞表面受体处的作用。Tetra 具有抗血管生成和抗肿瘤活性。
-
Ceranib-2
Ceranib-2 是一种神经酰胺酶抑制剂,在 SKOV3 细胞中的 IC50 为 28 μM。
-
Rigosertib
Rigosertib 是一种选择性、非 ATP 竞争性 PLK1 抑制剂 (IC50: 9 nM)。
021-51111890
购物车()
sales@molnova.cn

